AKT1 and breast cancer: A recent study reported that the phosphorylation of PRAS40 on Thr246 positively correlated with the activation of the PI3-kinase pathway and predicted an increased sensitivity of tumour cell growth to an Akt inhibitor in lung and breast cancer cell lines (Andersen et al, 2010).